Free Newsletter
FEATURES >> The most interesting logos in Pharma
Study: Januvia plays well with metformin
Merck's new diabetes drug Januvia delivered good blood sugar control over two years of treatment in combination with the older drug metformin, according to a new study the company is touting at the European Associaiton for the Study of Diabetes meeting. Report
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities



SHARE
WITH: